Arcticzymes Technologies ASA (B4V)

Currency in EUR
1.6000
0.0000(0.00%)
Delayed Data·
B4V Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
B4V is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.51501.6000
52 wk Range
1.04002.2200
Key Statistics
Bid/Ask
1.57 / 1.625
Prev. Close
1.6
Open
1.515
Day's Range
1.515-1.6
52 wk Range
1.04-2.22
Volume
-
Average Volume (3m)
1.3K
1-Year Change
-21.95%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
B4V Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Arcticzymes Technologies ASA Company Profile

ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing in Norway, Germany, Lithuania, France, Italy, the United Kingdom, rest of Europe, the United States, and internationally. The company offers shrimp alkaline phosphatase for cleanup prior to Sanger sequencing and next generation sequencing processes; cod UNG for use in viral and other molecular diagnostic assays for the removal of contaminating dU-DNA; salt active nucleases for the removal of nucleic acids during manufacturing of viral vectors, recombinant proteins, and other reagents; and double-strand specific DNases and derived kits for the removal of double stranded DNA. It also provides DNA/RNA polymerases for technology development for life science, molecular diagnostics, NGS, and synthetic biology; proteinase for microbiological diagnostics and liquid biopsies; and ligases for joining nucleic acids. The company serves the molecular tools, such as research and diagnostics, and biomanufacturing markets. The company was formerly known as Biotec Pharmacon ASA and changed its name to ArcticZymes Technologies ASA in June 2020. ArcticZymes Technologies ASA was founded in 1990 and is headquartered in Tromsø, Norway.

Compare B4V to Peers and Sector

Metrics to compare
B4V
Peers
Sector
Relationship
P/E Ratio
448.5x−3.4x−0.5x
PEG Ratio
−4.880.000.00
Price/Book
3.1x2.0x2.6x
Price / LTM Sales
9.5x7.2x3.2x
Upside (Analyst Target)
-57.0%42.0%
Fair Value Upside
Unlock25.2%6.6%Unlock

Earnings

Latest Release
May 08, 2025
EPS / Forecast
-0.06 / --
Revenue / Forecast
24.88M / --
EPS Revisions
Last 90 days

B4V Income Statement

FAQ

What Stock Exchange Does Arcticzymes Technologies ASA Trade On?

Arcticzymes Technologies ASA is listed and trades on the Frankfurt Stock Exchange stock exchange.

What Is the Stock Symbol for Arcticzymes Technologies ASA?

The stock symbol for Arcticzymes Technologies ASA is "B4V."

What Is the Arcticzymes Technologies ASA Market Cap?

As of today, Arcticzymes Technologies ASA market cap is 83.37M.

What Is Arcticzymes Technologies ASA's Earnings Per Share (TTM)?

The Arcticzymes Technologies ASA EPS (TTM) is 0.04.

From a Technical Analysis Perspective, Is B4V a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Arcticzymes Technologies ASA Stock Split?

Arcticzymes Technologies ASA has split 0 times.

How Many Employees Does Arcticzymes Technologies ASA Have?

Arcticzymes Technologies ASA has 53 employees.

What is the current trading status of Arcticzymes Technologies ASA (B4V)?

As of 30 Jul 2025, Arcticzymes Technologies ASA (B4V) is trading at a price of 1.60, with a previous close of 1.60. The stock has fluctuated within a day range of 1.52 to 1.60, while its 52-week range spans from 1.04 to 2.22.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.